Sort
172,184 grants matching “inflammation”
DIAN-TU: Tau Next Generation Prevention Trial
$16,720,909Randall J Bateman · Washington University · R01 · FY2022 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)
$16,618,207Liana G Apostolova · Indiana University Indianapolis · U01 · FY2021 · AG
TAS::75 0872::TAS TRANSLATIONAL NANOMEDICALTHERAPIES FOR CARDIAC & VASCULAR DIS
$16,447,515Zahi Fayad · Icahn School Of Medicine At Mount Sinai · N01 · FY2010 · HL
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$16,362,355Natalia S Rost · Massachusetts General Hospital · U19 · FY2024 · NS
DIAN-TU: Tau Next Generation Prevention Trial
$16,269,865Randall J Bateman · Washington University · R01 · FY2025 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)
$15,954,813Liana G Apostolova · Indiana University Indianapolis · U01 · FY2020 · AG
Chemoprophylaxis for HIV Prevention in Men
$15,906,431Robert M. Grant · J. David Gladstone Institutes · U01 · FY2010 · AI
DIAN-TU: Tau Next Generation Prevention Trial
$14,975,441Randall J Bateman · Washington University · R01 · FY2021 · AG
DIAN-TU: Tau Next Generation Prevention Trial
$14,973,241Randall J Bateman · Washington University · R01 · FY2020 · AG
Resuscitation Outcomes Consortium (ROC) Data Coordinating Center
$14,602,000Susanne May · University Of Washington · U01 · FY2013 · HL
Microbicide Trials Network
$14,379,710Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U01 · FY2009 · AI
Microbicide Trials Network
$14,315,989Sharon L Hillier · Magee-Women'S Res Inst And Foundation · UM1 · FY2012 · AI
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$14,058,964Natalia S Rost · Massachusetts General Hospital · U19 · FY2021 · NS
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$13,954,895Natalia S Rost · Massachusetts General Hospital · U19 · FY2023 · NS
Early Onset AD Consortium - the LEAD Study (LEADS)
$13,904,119Liana G Apostolova · Indiana University Indianapolis · U01 · FY2023 · AG
Functional MRI Core Facility
$13,738,965Peter Bandettini · National Institute Of Mental Health · ZIC · FY2025 · MH
Cardiovascular Inflammation Reduction Trial (CIRT)
$13,389,760Paul M. Ridker · Brigham And Women'S Hospital · U01 · FY2017 · HL
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)
$13,212,214Charles Decarli · University Of California At Davis · U19 · FY2021 · NS
Early Onset AD Consortium - the LEAD Study (LEADS)
$11,820,016Liana G Apostolova · Indiana University Indianapolis · U01 · FY2019 · AG
Prospective Study of the Gut Microbiome in Aging
$11,749,351Andrew T Chan · Massachusetts General Hospital · RF1 · FY2020 · AG
The WWAMI RCE for Biodefense and Emerging ID
$11,677,224University Of Washington · U54 · FY2004 · AI
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
$11,665,635James Dale Berry · Massachusetts General Hospital · U01 · FY2024 · NS
Novel Insights into Osteoarthritis, Pain and Function: MOST4
$11,514,044David Tobin Felson · Boston University Medical Campus · U19 · FY2023 · AG
The WWAMI RCE for Biodefense and Emerging ID
$11,401,047Samuel I. Miller · University Of Washington · U54 · FY2008 · AI
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
$11,203,040James Dale Berry · Massachusetts General Hospital · U01 · FY2023 · NS